If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
On CRSP's fourth-quarter 2024 earnings call, investors' focus will likely be on the sales figure of Casgevy, its first marketed product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback